Skip to main content

Advertisement

Log in

Design and Evaluation of Self-Nanoemulsifying Pellets of Repaglinide

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The aim of study was to develop self-nanoemulsifying pellets (SNEP) for oral delivery of poorly water soluble drug, repaglinide (RPG). Solubility of RPG in oily phases and surfactants was determined to identify components of self-nanoemulsifying drug delivery system (SNEDDS). The surfactants and cosurfactants were screened for their ability to emulsify oily phase. Ternary phase diagrams were constructed to identify nanoemulsification area for the selected systems. SNEDDS formulations with globule size less than 100 nm were evaluated for in vivo anti-hyperglycemic activity in neonatal streptozotocin rat model. A significant reduction in glucose levels was produced by optimized SNEDDS formulation in comparison to the control group. The optimized SNEDDS formulations were pelletized via extrusion/spheronization technique using microcrystalline cellulose and lactose. SNEP were characterized by X-ray powder diffraction and scanning electron microscopy. X-ray diffraction study indicated loss of crystallinity of RPG in SNEP. The SNEP exhibited good flow properties, mechanical strength and formed nanoemulsion with globule size less than 200 nm. SNEP showed in vitro release of more than 80% RPG in 10 min which was significantly higher than RPG containing reference pellets. In conclusion, our studies illustrated that RPG, a poorly water soluble drug can be successfully formulated into SNEP which can serve as a promising system for the delivery of poorly water soluble drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Humberstone AJ, Charman WN. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev. 1997;25:103–28.

    Article  CAS  Google Scholar 

  2. Culy C, Jarvis B. Repaglinide, a review of its therapeutic use in type 2 diabetes mellitus. Drugs. 2001;61:1625–60.

    Article  PubMed  CAS  Google Scholar 

  3. Malaisse W. Repaglinide, a new oral antidiabetic agent: a review of recent preclinical studies. Eur J Clin Invest. 1999;29:21–9.

    Article  PubMed  CAS  Google Scholar 

  4. Mandic Z, Gabelica V. Ionization, lipophilicity and solubility properties of repaglinide. J Pharm Biomed Anal. 2006;41(3):866–71.

    Article  PubMed  CAS  Google Scholar 

  5. Marbury TC, Ruckle JL, Hatorp V, Andersen MP, Nielsen KK, Huang WC, et al. Pharmacokinetics of repaglinide in subjects with renal impairment. Clin Pharmacol Ther. 2000;67:7–15.

    Article  PubMed  CAS  Google Scholar 

  6. Davis SN, Granner DK. Insulin, oral hypoglycemic agents and the pharmacology of the endocrine pancreas. In: Hardman JG, Limbrid LE, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. USA: McGraw-Hill; 2001. p. 1704–5.

    Google Scholar 

  7. Sinswat P, Matteucci ME, Johnston KP, Williams III RO. Dissolution rates and supersaturation behavior of amorphous repaglinide particles produced by controlled precipitation. J Biomed Nanotechnol. 2007;3:18–27.

    Article  CAS  Google Scholar 

  8. Desai NS, Bramhane DM, Nagarsenker MS. Repaglinide–cyclodextrin complexes: preparation, characterization and in vivo evaluation of antihyperglycemic activity. J Incl Phenom Macrocycl Chem. 2011;70(1–2):217–25.

    Article  CAS  Google Scholar 

  9. Zawar LR, Bari SB. Preparation, characterization and in vivo evaluation of antihyperglycemic activity of microwave generated repaglinide solid dispersion. Chem Pharm Bull. 2012;60(4):482–7.

    Article  PubMed  CAS  Google Scholar 

  10. Kavitha R, Sathali AAH. Enhancement of solubility of repaglinide by solid dispersion technique. Int J Chem Sci. 2012;10(1):377–90.

    CAS  Google Scholar 

  11. Patel M, Pandya N, Bhaskar VH. Preparation, characterization and in vitro evaluation of repaglinide binary solid dispersions with hydrophilic polymers. Int J Drug Dev & Res. 2011;3(2):107–17.

    CAS  Google Scholar 

  12. Seedher N, Kanojia M. Micellar solubilization of some poorly soluble antidiabetic drugs: a technical note. AAPS PharmSciTech. 2008;9(2):431–6.

    Article  PubMed  CAS  Google Scholar 

  13. Purvis T, Mattucci ME, Todd MC, Johnston KP, Williams III RO. Rapidly dissolving repaglinide powders produced by the ultra-rapid freezing process. AAPS PharmSciTech. 2007;8(3):E52–60.

    Article  Google Scholar 

  14. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58:173–82.

    Article  PubMed  Google Scholar 

  15. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2000;45:89–121.

    Article  PubMed  CAS  Google Scholar 

  16. Wei W, Yang W, Li Q. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur J Pharm Biopharm. 2006;63:288–94.

    Article  Google Scholar 

  17. Date A, Desai N, Dixit R, Nagarsenker M. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine. 2010;5(10):1595–616.

    Article  PubMed  CAS  Google Scholar 

  18. Chang RK, Raghavan KS, Hussain MA. A study on gelatin capsule brittleness: moisture transfer between the capsule shell and its content. J Pharm Sci. 1998;87:556–8.

    Article  PubMed  CAS  Google Scholar 

  19. Mei X, Etzler FM, Wang Z. Use of texture analyzer to study hydrophilic solvent effects on the mechanical properties of hard gelatin capsules. Int J Pharm. 2006;324:128–35.

    Article  PubMed  CAS  Google Scholar 

  20. Mahmoud EA, Bendas ER, Mohamed MI. Preparation and evaluation of self-nanoemulsifying tablets of carvedilol. AAPS Pharm Sci Tech. 2009;10:183–92.

    Article  CAS  Google Scholar 

  21. Dixit RP, Nagarsenker MS. Formulation and in vivo evaluation of self-nanoemulsifying granules for oral delivery of a combination of ezetimibe and simvastatin. Drug Dev Ind Pharm. 2008;34:1285–96.

    Article  PubMed  CAS  Google Scholar 

  22. Balakrishnan P, Lee BJ, Oh DH, Kim JO, Hong MJ, Jee JP, et al. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm. 2009;72:539–45.

    Article  PubMed  CAS  Google Scholar 

  23. Tuleu C, Newton JM, Rose J, Euler D, Saklatvala R, Clarke A, et al. Comparative bioavailability study in dogs of a self emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone. J Pharm Sci. 2004;93:1495–502.

    Article  PubMed  CAS  Google Scholar 

  24. Newton JM, Pinto MR, Podczeck F. The preparation of pellets containing a surfactant or a mixture of mono- and di-glycerides by extrusion/spheronization. Eur J Pharm Sci. 2007;30:333–42.

    Article  PubMed  CAS  Google Scholar 

  25. Xiongwei H, Chen L, Dingxiong C, Jing Z, Zhihong L, Wei W, et al. Sirolimus solid self-microemulsifying pellets: formulation development, characterization and bioavailability evaluation. Int J Pharm. 2012;438:123–33.

    Article  Google Scholar 

  26. Abdalla A, Mäder K. Preparation and characterization of a self emulsifying pellet formulation. Eur J Pharm Biopharm. 2007;66:220–6.

    Article  PubMed  CAS  Google Scholar 

  27. Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm. 2007;329:166–72.

    Article  PubMed  CAS  Google Scholar 

  28. Pouton CW, Porter CJH. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 2008;60:625–37.

    Article  PubMed  CAS  Google Scholar 

  29. Porter CJH, Pouton CW, Cuine JF, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev. 2008;60:673–91.

    Article  PubMed  CAS  Google Scholar 

  30. Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm. 2000;50(1):179–88.

    Article  PubMed  CAS  Google Scholar 

  31. Newton M, Petersson J, Podczeck F, Clarke A, Booth S. The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture. J Pharm Sci. 2001;90:987–95.

    Article  PubMed  CAS  Google Scholar 

  32. Shah NH, Phuapradit W, Zhang Y, Ahmed H, Malick AW. Lipid-Based Isotropic Solutions: Design Considerations. In: Hauss DJ, editor. Oral lipid-based formulations enhancing the bioavailability of poorly water-soluble drugs. Informa Healthcare USA, Inc; 2007. p. 129–148.

Download references

Acknowledgments

The authors are thankful to USV India Pvt. Limited, India for providing gift sample of repaglinide. We are thankful to Colorcon Asia Pvt. Ltd., India; Gattefosse India Pvt Ltd., India; BASF India Ltd., India; Karlshamns AB., Sweden; S. Zaveri & Co., India; for providing gift samples of oils and surfactants. The authors are also thankful to Associated Capsules, India, for gift sample of hard gelatin capsules. The authors wish to thank Mr. Nilesh Kulkarni, Tata Institute of Fundamental Research (TIFR), Mumbai, India for carrying out X-ray diffraction studies. The authors are thankful to the Department of Biotechnology (DBT), New Delhi, for providing fellowship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. S. Nagarsenker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Desai, N.S., Nagarsenker, M.S. Design and Evaluation of Self-Nanoemulsifying Pellets of Repaglinide. AAPS PharmSciTech 14, 994–1003 (2013). https://doi.org/10.1208/s12249-013-9990-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-013-9990-9

Key words

Navigation